Advent Therapeutics Overview

  • Founded
  • 2014

Founded
  • Status
  • Private

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $252K

  • Investors
  • 3

Advent Therapeutics General Information

Description

Developer of legacy drugs designed to address serious unmet medical needs in the underserved neonatal and pediatric patient populations. The company's drugs are prenatal, neonatal and pediatric drugs for orphans to cure disorders in newborn infants in the intensive care unit (ICU), enabling pediatricians and healthcare professionals to care for the fragile in an advanced manner.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • 6500 Old Carversville Road
  • Lumberville, PA 18933-9729
  • United States

Advent Therapeutics Timeline

2019202020212022
Financing Round

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Advent Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Grant 15-Aug-2020 $252K 00000 Completed Generating Revenue
4. Grant 01-Jan-2020 00.000 00000 Completed Generating Revenue
3. Early Stage VC 12-Sep-2016 00000 00000 Completed Startup
2. Seed Round 19-Aug-2015 $120K $120K Completed Startup
1. Seed Round 11-Dec-2014 Completed Startup
To view Advent Therapeutics’s complete valuation and funding history, request access »

Advent Therapeutics Patents

Advent Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-3170810-A1 Compositions of vitamin a palmitate, processes for their preparation, uses and methods comprising them Pending 11-Feb-2020 000000000
AU-2021220126-A1 Compositions of vitamin a palmitate, processes for their preparation, uses and methods comprising them Pending 11-Feb-2020

Advent Therapeutics Executive Team (2)

Name Title Board Seat Contact Info
Thomas Hofmann Ph.D Chief Scientific Advisor
David Lopez ESQ Co-Founder, Chief Executive Officer, Chief Financial Officer, Chief Business Officer & President
To view Advent Therapeutics’s complete executive team members history, request access »

Advent Therapeutics Board Members (1)

Name Representing Role Since
Eric Floyd Ph.D Self Board Member 000 0000
To view Advent Therapeutics’s complete board members history, request access »

Advent Therapeutics Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
National Institutes of Health Government 000 0000 000000 0
U.S. Department of Health and Human Services Government 000 0000 000000 0
Ben Franklin Technology Partner of Southeastern Pennsylvania Venture Capital Minority 000 0000 000000 0
To view Advent Therapeutics’s complete investors history, request access »